# Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder

> **NCT00050206** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 130 (—)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00050206
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 130 (—)
- **Last updated:** 2007-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00050206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00050206, "Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00050206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*